~~<i id='2C5D92A032'><strike id='2C5D92A032'><tt id='2C5D92A032'><pre id='2C5D92A032'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

leisure time

hotspot

author：knowledge 2025-09-05 15:33:54 - browse：8

A device component from Paradromics Inc., one of the main brain-computer interface players racing to get to market. Courtesy Paradromics Inc.

Rodney Gorham loves fast, flashy cars: His WhatsApp profile picture is a bright yellow Corvette Stingray. “I don’t get to drive it anymore,” Gorham told STAT in a text.

Gorham, a 63-year-old living in Australia, has amyotrophic lateral sclerosis. He can’t speak, and can move his hands and legs only a little. But he is able to control his computer with his thoughts, aided by a brain-computer interface developed by the startup Synchron.

“It has been exciting to be involved,” Gorham wrote.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Virginia high school admissions case could be legal follow
Next article： Addiction experts warn against a second 'war on drugs'

focus

explore

entertainment

hotspot

focus

Prostatecancercellsseenunderthemicroscope.NIHProstatecancertendstobethetortoiseoftumors,growingandsp

WSS

H5N1 bird flu outbreak: Second human case reported, in Michigan

Fentanyl is making it harder to start addiction treatment

For longer

How a billionaire couple greased the skids for Pelosi’s drug pricing bill

H5N1 virus can be tracked in retail milk, scientists say

Cytokinetics CEO stresses company can launch heart drug on its own

leisure time

hotspot

focus

Indiana Supreme Court upholds abortion ban, says state constitution gives only limited protections

Venture capitalist Bob Kocher on the state of digital health

Medical records are filled with copy

Readout Newsletter: H5N1 bird flu vaccine, Cytokinetics, Gilead

Tori Bowie and the unacceptable rates of Black maternal death

Analysis of pharma R&D ranks Novo Nordisk, J&J above their peers

Moonlake's readout produced a cash windfall. Risks remain

Big Tobacco's 'harm reduction': Is it for real, or a sham?

Hepatitis C has a cure — but many Americans still lack access to it

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

focus

Fentanyl is making it harder to start addiction treatment

UnitedHealth argues against case alleging wrongful AI care denials

FDA poised to publish guidelines for clinical trial diversity

Readout Newsletter: Eli Lilly, AstraZeneca, Bristol Meyers Squibb

Solving academic medical centers' existential crisis

Bird flu surveillance in wastewater gets boost from consortium

explore

entertainment

hotspot

focus